In this Section |
5065.0 Drug Policy & Pharmacy ServicesWednesday, November 11, 2009: 8:30 AM
Oral
This session will consider the impact on safety and costs and/or the lack of muscle in regulation around patent rights, direct-to-consumer-advertising, and off-label advertising, and several initiatives that are being introduced to improve patient safety and outcomes while simultaneously reducing costs.
Session Objectives: 1. Identify safety, cost-containment and regulatory issues around direct-to-consumer advertising, and off-label advertising.
2. Assess the impact of the Drug Price Competition and Patent Term Restoration Act on generic entry of products and generic competition.
3. Describe the cost-containment and improved patient outcome potential of medication therapy management and the use of patient medication lists.
Moderator:
Maggie Huff-Rousselle, MA, MBA, PhD
8:30 AM
9:00 AM
9:30 AM
See individual abstracts for presenting author's disclosure statement and author's information. Organized by: Medical Care CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)
See more of: Medical Care
|